Results 211 to 220 of about 100,222 (232)

Meropenem

Drugs, 2012
Harriet M Lamb
exaly  

Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2017
Mariana Castanheira, Michael D Huband, Rodrigo E Mendes   +2 more
exaly  

Effects of KPC Variant and Porin Genotype on the In Vitro Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2019
Ellen G Kline, Yohei Doi, M Hong Nguyen
exaly  

Meropenem

Reactions Weekly, 2010
Anton Peleg, Margaret Salmon
openaire   +2 more sources

Ultrahigh antibacterial efficacy of meropenem-loaded chitosan nanoparticles in a septic animal model

Carbohydrate Polymers, 2017
Ayat Abdelkader, Mohamed A El-Mokhtar, Mahmoud Elsabahy   +2 more
exaly  

Pharmacokinetics and pharmacodynamics of meropenem in children with severe infection

International Journal of Antimicrobial Agents, 2016
Suntara Eakanunkul, Satja Issaranggoon na Ayuthaya   +1 more
exaly  

Meropenem

Reactions Weekly, 2018
openaire   +2 more sources

Pharmacokinetics and Pharmacodynamics of Meropenem in Elderly Chinese with Lower Respiratory Tract Infections

Drugs and Aging, 2012
Bei He, Suodi Zhai
exaly  

Meropenem

Reactions Weekly, 2011
openaire   +1 more source

In Vitro Activity of Meropenem-Vaborbactam against Clinical Isolates of KPC-Positive Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2018
Meredith A Hackel, Olga Lomovskaya, Michael N Dudley   +2 more
exaly